Although upper respiratory illnesses are not a primary focus for pediatric gastroenterologists, due to their frequency, we see them quite a bit. Even with my limited exposure, I frequently receive requests for medications to reduce the symptoms of cough and runny nose.
My approach has typically been to explain that I don’t believe that cough and cold medicines (CCMs) are effective and can be harmful, especially in young children. This explanation is in agreement with efforts that both the pharmaceutical industry and the Food and Drug Administration (FDA) took in 2007 and 2008 to limit the use of over the counter (OTC) CCMs in young children. The American Academy of Pediatrics has gone further and advised against their usage in children under age 6 years. These recommendations came in part due to lack of efficacy of these agents but also due to the recognized potential for adverse effects, including fatalities.
Recently, a study (J Pediatr 2014; 165:1024-8) has shown that despite labeling changes on CCMs there has been virtually no impact on the use of OTC CCMs. Using information from administrative databases, this study compared prescribing patterns 2005-2006 with 2009-2010 in children aged ≤ 12 years. Results: There was an increase in use of OTC CCM used in ambulatory clinics (6.3% to 11.1%) but a decrease in the use of prescription CCMs 6.7% to 2.9%. The OTC CCM use in children <2 years was essentially unchanged between the two timeframes (6.8% compared to 6.5%)
Bottomline: If parents and physicians want to do what is best for the children they care for, then more effort is needed to stop the widespread use of CCMs. Prevention with influenza vaccination and proper hand hygiene are measures which can help.
A separate problem is the misuse of antibiotics for upper respiratory illnesses. This is widespread as well. While this blog has discussed antibiotic resistance and antimicrobial stewardship, a recent article (NEJM 2014; 371: 1761-63) provided a few new ideas on this subject.
- First, the authors note that modern medicine is entirely dependent on antibiotics. “Two major ways that modern medicine saves lives are through antibiotic treatment of severe infections and the performance of medical and surgical procedures under the protection of antibiotics.”
- Second, the authors note that “as people in wealthier regions run out of effective antibiotics, they come to share the lot of people in poorer regions who can’t afford them to begin with.”
- Third, the authors point out that antibiotic resistance was recognized in 1945 by Alexander Fleming and Howard Walter Florey when they accepted the Nobel Prize for the discovery of penicillin.
The authors then outline the areas that need to be addressed to diminish the prospects of ineffective antibiotics:
- Prevention with vaccination and sanitation
- Leadership to coordinate global surveillance and manage rewards for proper usage
- Access to subsidized appropriate usage in poorer countries
- Conservation of antibiotic usage –restrain use of antibiotics in agriculture/farming
- Conservation through appropriate use of prescriptions
Related blog posts:
- What the “Post-Antibiotic Age” Really Means | gutsandgrowth
- Antibiotic resistance: doomed to repeat | gutsandgrowth
- Preventing lethal antibiotic resistant outbreaks …
- Hospital-based Antimicrobial Stewardship | gutsandgrowth